Sutro Biopharma (STRO) Interest Coverage Ratio (QoQ) (2017 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Sutro Biopharma | 248.39 Mn | 248.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 76.68% |
| Jun 30, 2022 | 45.23% |
| Mar 31, 2022 | -4.04% |
| Dec 31, 2021 | -35.39% |
| Sep 30, 2021 | -265.28% |
| Jun 30, 2021 | 47.75% |
| Mar 31, 2021 | -300.74% |
| Dec 31, 2020 | 340.85% |
| Sep 30, 2020 | 17.52% |
| Jun 30, 2020 | 69.41% |
| Mar 31, 2020 | -0.39% |
| Dec 31, 2019 | -62.11% |
| Sep 30, 2019 | -0.48% |
| Jun 30, 2019 | 9.68% |
| Mar 31, 2019 | -343.71% |
| Dec 31, 2018 | 124.00% |
| Sep 30, 2018 | -188.20% |
| Jun 30, 2018 | 178.03% |
| Mar 31, 2018 | 24.05% |
| Dec 31, 2017 | -787.78% |